BNET Industries

Hydromer Inc.

Market Cap:$3.5M

Last Fiscal Year Sales:$8.0M

Public
US

Dow Jones Description

Hydromer, Inc. is an innovative, broad-based, technology-driven company engaged in the business of inventing, developing, patenting, licensing, manufacturing, and selling hydrophilic polymer-based products and coatings for commercial markets. While maintaining its industry leadership position in permanent lubricious coatings for medical devices, Hydromer constantly strives to build upon its current technologies - successfully expanding its technology/product base to include anti-fog and condensation control coatings for optical applications, water-resistant film formers and allergen barriers for cosmetics, and unique hydrogels for wound care and pharmaceutical delivery applications. Hydromer, Inc. was founded in 1980 to capitalize on the newly developed and patented technologies in hydrophilic complexing polymers. These polymers exhibit unique properties by imparting biological compatibilities to medical devices, particularly in the cardiovascular area for devices like stents, including the emerging stent drug delivery, distal protection devices and therapeutic catheters. The initial great success on licensing these patents gave rise to an entire family of patents, covering much larger fields of application. In addition to medical devices, products are licensed and/or sold for use in color cosmetics ; personal care products such as razor blades to make them glide easier, hair dyes and hair conditioners; as coatings for boats to reduce the friction between the boat and...

Chairman of the Board, Chief Executive Officer and President

Manfred F Dyck

Number of Employees 74

Contact Information

35 Industrial Pkwy

Somerville, New Jersey 08876

hydromer.com

9085262828

Peer Companies

NAICS Code Lessors of Nonfinancial Intangible Assets (except Copyrighted Works): 533110

News & Analysis

hydromer inc. - All News and Analysis

Small Firms See Big Promise in Coated Stents

- 2007-05-28

BRANCHBURG Risks found in the current generation of devices open the door to newcomers PROBLEMS BESETTING Johnson & Johnson and other big makers of drug-coated stents are creating opportunities for small Garden State companies that are developing new stent technologies. Drug-coated stents - medicated metal scaffolds that prop...

Tags: Boston Scientific Corp., HEALTHCARE, Hydromer Inc., Rutgers University, Strategy, technology

page 1 of 1

Decision Makers

Name (plus bio)	Position
Robert Y Lee	Vice President of Finance, Chief Financial Officer and Treasurer
Martin C Dyck	Executive Vice President, Operations and President Biosearch Medical Products Subsidiary
Martin Von Dyck	Executive Vice President
Robert J Moravsik	Senior Vice President, General Counsel and Secretary
John Konar	Vice President of Quality Assurance and Director of Human Resources
Rainer Gruening	Vice President of R&D

Board of Directors

Name (plus bio)	Position
Manfred F Dyck	Chairman of the Board, Chief Executive Officer and President

Manfred F. Dyck , President and CEO, has a BS in Chemical Engineering from T.I.S. in Germany and did graduate work towards a doctorate in chemistry and physiology at the University of Miami, in Coral Gables, Florida. Mr. Dyck's credits include 6 patents (sole inventor) and over thirty publications. His experiences include biomedical product development at Ethicon, Inc. and has served as a member of the President's Staff at Cordis Corporation, in Miami, a manufacturer of medical devices. Prior he was Chief Chemist with Polyplex A/S, Copenhagen, the premier company in Denmark for polymer-synthesis.

Organization	Position	Status
Hydromer, Inc.	Chairman of the Board, Chief Executive Officer and President	Current
Biosearch LLC, Inc	President	Current
Somerset Medical Center	Chief of Surgery	Former
Siemens Medical Systems	Vice President of Quality Assurance	Former
Somerset Medical Center	Medical Doctor	Former
Robert Wood Johnson Medical School - University of Medicine & Dentistry of New Jersey	Professor of Medicine	Former
University of Miami	Doctorate In Chemistry and Physiology	Former
Cordis Corporation	member	Former

Organization	Position	Status
Hydromer, Inc.	Vice President of Finance, Chief Financial Officer and Treasurer	Current
New Jersey & Company	Attorney	Current
The Bureau of National Affairs, Inc.	Vice President	Former
The Bureau of National Affairs, Inc.	General Counsel	Former

Organization	Position	Status
Hydromer, Inc.	Executive Vice President, Operations and President Biosearch Medical Products Subsidiary	Current
Hydromer, Inc.	Vice President of Operations of the Company	Former

Organization	Position	Status
Hydromer, Inc.	Executive Vice President	Current

Organization	Position	Status
Hydromer, Inc.	Senior Vice President, General Counsel and Secretary	Current
Hydromer, Inc.	Secretary	Current
The Bureau of National Affairs, Inc.	Vice President	Former
The Bureau of National Affairs, Inc.	General Counsel	Former
Seton Hall University	Doctorate of Law	Former
Stevens Institute of Technology	Masters Degree In Computer Science	Former
Tri-State University	B.S. Degree In Aerospace Engineering	Former

Organization	Position	Status
Hydromer, Inc.	Vice President of Quality Assurance and Director of Human Resources	Current
Biosearch LLC, Inc	Director of Human Resources	Former

Rainer Gruening joined the Company as Vice-President of Research and Development in June 2001, and in May 2006 became VP of Intellectual Property. With a PhD in Chemistry from the University of Marburg in Germany, his background includes service with Bayer AG/Deutsche Solvay Werke, Troy, G+G International and AM Cosmetics in areas including international regulatory affairs, coatings technology and anti-microbials. Mr. Gruening authored and/or co-authored 17 patents and 35 publications on synthesis and formulation of anti-microbials for paint and coatings, cosmetics, personal care products, medical coatings, adhesives, marine anti-fouling and metal working fluids and developed dossiers, safety assessments and GMP documentation. Additionally, he implemented FDA/CTFA, European and Japanese compliance requirements for raw materials and formulation restrictions.